JANSSEN PHARMS FDA Approval NDA 018533

NDA 018533

JANSSEN PHARMS

FDA Drug Application

Application #018533

Documents

Letter2013-07-29
Label2014-03-05
Letter2014-02-27
Label2013-07-25
Medication Guide2013-07-25
Other Important Information from FDA2014-02-07

Application Sponsors

NDA 018533JANSSEN PHARMS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NIZORALKETOCONAZOLE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1981-06-12PRIORITY
LABELING; LabelingSUPPL2AP1983-06-23PRIORITY
LABELING; LabelingSUPPL3AP1986-06-30PRIORITY
LABELING; LabelingSUPPL4AP1983-06-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1983-04-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1983-04-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1983-09-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1984-07-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1984-07-09PRIORITY
LABELING; LabelingSUPPL11AP1986-06-30PRIORITY
LABELING; LabelingSUPPL12AP1986-06-30PRIORITY
LABELING; LabelingSUPPL13AP1986-06-30PRIORITY
LABELING; LabelingSUPPL14AP1986-06-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1985-06-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1988-05-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1988-07-08PRIORITY
LABELING; LabelingSUPPL18AP1989-04-14PRIORITY
LABELING; LabelingSUPPL19AP1991-03-15PRIORITY
LABELING; LabelingSUPPL20AP1992-12-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1992-10-13PRIORITY
LABELING; LabelingSUPPL22AP1992-12-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1993-09-20PRIORITY
LABELING; LabelingSUPPL24AP1994-03-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1995-09-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1995-09-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL28AP1995-09-15PRIORITY
LABELING; LabelingSUPPL29AP1996-07-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1996-04-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL31AP1996-06-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL32AP1998-03-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL33AP1998-05-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1998-07-24PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL36AP1999-04-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL37AP1999-09-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL38AP2002-04-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL39AP2002-08-13PRIORITY
LABELING; LabelingSUPPL40AP2013-07-25PRIORITY
LABELING; LabelingSUPPL41AP2014-02-25PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL40Null0
SUPPL41Null0

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18533
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["Medication Guide","http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM362592.pdf"]
            [products] => [{"drugName":"NIZORAL","activeIngredients":"KETOCONAZOLE","strength":"200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"02\/25\/2014","submission":"SUPPL-41","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/018533s041lbl.pdf\"}]","notes":""},{"actionDate":"07\/25\/2013","submission":"SUPPL-40","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/018533s040lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"NIZORAL","submission":"KETOCONAZOLE","actionType":"200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-02-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.